Korean J Med.  2013 Nov;85(5):535-539.

Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1

Affiliations
  • 1Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea. shs7436@dsmc.or.kr

Abstract

Neurofibromatosis type 1 (NF1) is a genetic disease characterized by neoplastic and non-neoplastic disorders involving tissues of neuroectodermal and mesenchymal origin. NF1 is caused by mutations in the NF1 gene, which is found on chromosome 17q11.2. Patients with NF1 are at increased risk of developing soft tissue sarcomas that arise within the stromal compartment of the gastrointestinal tract, termed gastrointestinal stromal tumors (GISTs). GISTs associated with neurofibromatosis differ from sporadic GISTs, particularly with respect to their lower response rate to imatinib. We recently experienced a case involving a 45-year-old man with NF1 who was admitted to the hospital with epigastric pain and vomiting. Abdominal computed tomography revealed a duodenal GIST with pancreatic invasion. He had a base substitution mutation involving replacement of 2041 cytosine with thymine. He was treated successfully with a surgical operation and adjuvant imatinib therapy.

Keyword

Neurofibromatosis; Gastrointestinal stromal tumors; Imatinib

MeSH Terms

Benzamides
Cytosine
Gastrointestinal Stromal Tumors*
Gastrointestinal Tract
Genes, Neurofibromatosis 1
Humans
Middle Aged
Neural Plate
Neurofibromatoses*
Neurofibromatosis 1*
Piperazines
Pyrimidines
Sarcoma
Thymine
Vomiting
Imatinib Mesylate
Benzamides
Cytosine
Piperazines
Pyrimidines
Thymine
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr